Comments

Hoth Therapeutics

HOTHNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.820000
-0.0022-0.27%
Pre-Market: 8:27 AM EDT
15 minutes delayed
Hoth Therapeutics (HOTH) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$14.00
Lowest Price Target1
$4.00
Consensus Price Target1
$7.50

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Hoth Therapeutics (NASDAQ:HOTH) Stock, Analyst Ratings, Price Targets, Forecasts

Hoth Therapeutics Inc has a consensus price target of $7.5 based on the ratings of 5 analysts. The high is $14 issued by EF Hutton on April 27, 2023. The low is $4 issued by HC Wainwright & Co. on July 22, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and EF Hutton on July 22, 2024, April 5, 2024, and April 2, 2024, respectively. With an average price target of $5 between HC Wainwright & Co., HC Wainwright & Co., and EF Hutton, there's an implied 509.76% upside for Hoth Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Feb
0
0
0
0
Apr
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
EF Hutton
EF Hutton
Benchmark
EF Hutton

1calculated from analyst ratings

Analyst Ratings for Hoth Therapeutics

Buy NowGet Alert
07/22/2024Buy Now387.8%HC Wainwright & Co.
Raghuram Selvaraju
$4 → $4ReiteratesBuy → BuyGet Alert
04/05/2024Buy Now387.8%HC Wainwright & Co.
Raghuram Selvaraju
 → $4ReiteratesBuy → BuyGet Alert
04/02/2024Buy Now753.66%EF Hutton
Tim Moore
$6.5 → $7MaintainsBuyGet Alert
02/05/2024Buy Now387.8%HC Wainwright & Co.
Raghuram Selvaraju
 → $4Initiates → BuyGet Alert
09/14/2023Buy Now814.63%EF Hutton
Elemer Piros
$12 → $7.5MaintainsBuyGet Alert
08/23/2023Buy Now1607.32%EF Hutton
Elemer Piros
 → $14Assumes → BuyGet Alert
06/20/2023Buy Now509.76%Benchmark
Bruce Jackson
 → $5ReiteratesSpeculative Buy → Speculative BuyGet Alert
06/01/2023Buy Now1607.32%EF Hutton
Elemer Piros
 → $14Assumes → BuyGet Alert
04/27/2023Buy Now1607.32%EF Hutton
Constantine Davides
 → $14Reiterates → BuyGet Alert
04/10/2023Buy Now509.76%Benchmark
Bruce Jackson
 → $5Reiterates → Speculative BuyGet Alert
04/03/2023Buy Now1607.32%EF Hutton
Constantine Davides
$33 → $14MaintainsBuyGet Alert
12/30/2022Buy Now3924.39%EF Hutton
Constantine Davides
$45 → $33MaintainsBuyGet Alert
03/31/2022Buy Now204.88%EF Hutton
Constantine Davides
$68.75 → $62.5MaintainsBuyGet Alert

FAQ

Q

What is the target price for Hoth Therapeutics (HOTH) stock?

A

The latest price target for Hoth Therapeutics (NASDAQ:HOTH) was reported by HC Wainwright & Co. on July 22, 2024. The analyst firm set a price target for $4.00 expecting HOTH to rise to within 12 months (a possible 387.80% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hoth Therapeutics (HOTH)?

A

The latest analyst rating for Hoth Therapeutics (NASDAQ:HOTH) was provided by HC Wainwright & Co., and Hoth Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Hoth Therapeutics (HOTH)?

A

There is no last upgrade for Hoth Therapeutics

Q

When was the last downgrade for Hoth Therapeutics (HOTH)?

A

There is no last downgrade for Hoth Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Hoth Therapeutics (HOTH)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hoth Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hoth Therapeutics was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.

Q

Is the Analyst Rating Hoth Therapeutics (HOTH) correct?

A

While ratings are subjective and will change, the latest Hoth Therapeutics (HOTH) rating was a reiterated with a price target of $4.00 to $4.00. The current price Hoth Therapeutics (HOTH) is trading at is $0.82, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch